Stay updated on IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.

Latest updates to the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s display footer revision/version label was updated from **v3.5.2** to **v3.5.3**, indicating a maintenance or release update for the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check24 days agoChange DetectedReplimune, Inc. was added and Replimune Inc. was removed. Revision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.2%

- Check53 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous entry v3.4.3 was removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe history now includes Revision: v3.4.3 and removes Revision: v3.4.2 from the page's history.SummaryDifference0.1%

- Check82 days agoChange DetectedNew entries were added to the record history: 'Study Status' on 2026-02-13 and a value '43' on 2026-02-12, with a deletion recorded on 2025-12-17.SummaryDifference0.2%

- Check89 days agoChange DetectedThe record history now includes a new revision entry: v3.4.2. The previous revision v3.4.1 has been removed from the listing.SummaryDifference0.1%

Stay in the know with updates to IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGNYTE Study: RP1 Monotherapy and Combo with Nivolumab Clinical Trial page.